<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinmed</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical Medicine (Russian Journal)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0023-2149</issn><issn pub-type="epub">2412-1339</issn><publisher><publisher-name>ООО «Медицинское информационное агентство»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/0023-2149-2025-103-8-9-596-605</article-id><article-id custom-type="elpub" pub-id-type="custom">clinmed-1260</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Влияние микробиома полости рта на риск возникновения сердечнососудистых заболеваний</article-title><trans-title-group xml:lang="en"><trans-title>The influence the oral microbiome on the risk of cardiovascular diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7479-418X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Резник</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Reznik</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Резник Елена Владимировна — д-р мед. наук, врач высшей категории, заведующий кафедрой пропедевтики внутренних болезней №2 Института клинической медицины</p><p>Researcher ID N-6856-2016 </p><p>Москва </p></bio><bio xml:lang="en"><p>Elena V. Reznik — Doctor of Medical Sciences, Doctor of the Highest category, Head of the Department of Propaedeutics of Internal Diseases №2 of the Institute of Clinical Medicine</p><p>Researcher ID N-6856-2016 </p><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4723-6067</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Копецкий</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kopetskiy</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Копецкий Игорь Сергеевич — д-р мед. наук, профессор, заведующий кафедрой терапевтической стоматологии Института стоматологии</p><p>Москва </p></bio><bio xml:lang="en"><p>Igor S. Kopetskiy — Doctor of Medical Sciences, Professor of Therapeutic Dentistry, Head of the Department of Therapeutic Dentistry</p><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6150-0282</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Побожьева</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pobozhieva</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Побожьева Людмила Владимировна — канд. мед. наук, доцент кафедры терапевтической стоматологии Института стоматологии</p><p>Москва </p></bio><bio xml:lang="en"><p>Ludmila V. Pobozhieva — Candidate of Medical Sciences, Associate Professor of Therapeutic Dentistry,</p><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4580-8851</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яровой</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Iarovoi</surname><given-names>M. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яровой Максим Дмитриевич — студент 6-го курса лечебного факультета </p><p>Москва </p></bio><bio xml:lang="en"><p>Maksim D. Iarovoi — 6th year student of the Federal State Autonomous Educational Institution of Higher Education</p><p>Moscow </p></bio><email xlink:type="simple">jarovojmax@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5488-5786</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кафарская</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kafarskaya</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафарская Людмила Ивановна — д-р мед. наук, профессор, заведующая кафедрой микробиологии и вирусологии ИПМ</p><p>Москва </p></bio><bio xml:lang="en"><p>Ludmila I. Kafarskaya — Doctor of Medical Sciences, Professor, Head of the Department of Microbiology and Virology, Institute of Microbiology and Virology</p><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России (Пироговский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>01</month><year>2026</year></pub-date><volume>103</volume><issue>8-9</issue><fpage>596</fpage><lpage>605</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Резник Е.В., Копецкий И.С., Побожьева Л.В., Яровой М.Д., Кафарская Л.И., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Резник Е.В., Копецкий И.С., Побожьева Л.В., Яровой М.Д., Кафарская Л.И.</copyright-holder><copyright-holder xml:lang="en">Reznik E.V., Kopetskiy I.S., Pobozhieva L.V., Iarovoi M.D., Kafarskaya L.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinmedjournal.com/jour/article/view/1260">https://www.clinmedjournal.com/jour/article/view/1260</self-uri><abstract><p>Обоснование. На возникновение сердечно-сосудистых заболеваний (ССЗ) влияет множество модифицируемых и немодифицируемых факторов риска, количество которых постоянно растет. Одним из таких факторов может быть нарушение состава микробиома полости рта. Его структура достаточно вариабельна. Преобладание тех или иных микроорганизмов может не только вызвать местную патологию, такую как развитие кариеса или пародонтита, но и привести к системным изменениям. Наиболее патогенными бактериями, обитающими в ротовой полости, являются Porphyromonas gingivalis, Streptococcus mutans, бактерии рода Eikenella, колонизация которых является фактором риска возникновения инфекционного эндокардита (ИЭ), а также ишемической болезни сердца (ИБС). Профилактика сердечно-сосудистых заболеваний должна быть направлена не только на уже известные факторы риска возникновения сердечно-сосудистой патологии (ожирение, эмоциональное напряжение, метаболический синдром, курение и др.), но и на микробиом полости рта. Цель. Доказать наличие взаимосвязи между патологией органов полости рта и развитием ССЗ. Материал и методы. Анализ публикаций проводился с использованием следующих баз данных: PubMed, РИНЦ, Science Direct, КиберЛенинка, Web of Science. В литературный обзор вошли 94 источника за последние 10 лет. Заключение. Состав микробиома рта играет существенную роль в патогенезе ССЗ. Бактерии синтезируют вещества, опосредующие иммунные, воспалительные реакции, а также могут мигрировать в кровоток, способствуя развитию атеросклероза, ИБС и ИЭ, внося вклад в развитие и прогрессирование артериальной гипертензии и хронической сердечной недостаточности. Необходимо уделять внимание профилактике дисбиоза полости рта как фактора риска развития и прогрессирования соматической патологии.</p></abstract><trans-abstract xml:lang="en"><p>Justification. The occurrence of cardiovascular diseases (CVD) is influenced by many modifiable and unmodifiable risk factors, the number of which is constantly growing. One of these factors can be a violation of the composition of the oral microbiome. Its structure is quite variable. The predominance of certain microorganisms can not only cause local pathology, such as the development of caries or periodontitis, but also lead to systemic changes. The most pathogenic bacteria living in the oral cavity are Porphyromonas gingivalis, Streptococcus mutans, and bacteria of the genus Eikenella, the colonization of which is a risk factor for infectious endocarditis (IE), as well as coronary heart disease (CHD). Prevention of CVD should be aimed not only at the already known risk factors for cardiovascular pathology (obesity, emotional stress, metabolic syndrome, smoking, etc.), but also at the oral microbiome. Goal. To prove the existence of a relationship between the pathology of the oral cavity and the development of CVD. Material and methods. The analysis of publications was carried out using the following databases: PubMed, RSCI, Science Direct, CyberLeninka, Web of Science. The literature review includes 94 sources over the past 10 years. Conclusion. The composition of the oral microbiome plays a significant role in the pathogenesis of CVD. Bacteria synthesize substances that mediate immune and inflammatory reactions, and can also migrate into the bloodstream, contributing to the development of atherosclerosis, CHD and IE, contributing to the development and progression of hypertension and chronic heart failure. It is necessary to pay attention to the prevention of oral dysbiosis as a risk factor for the development and progression of somatic pathology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микробиом</kwd><kwd>полость рта</kwd><kwd>кариес</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>пародонтит</kwd><kwd>профилактика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>microbiome</kwd><kwd>oral cavity</kwd><kwd>caries</kwd><kwd>cardiovascular disease</kwd><kwd>periodontitis</kwd><kwd>prophylaxis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов Д.О., Орел В.И., Александрович Ю.С. и др. Заболевания сердечно-сосудистой системы как причина смертности в Российской Федерации: пути решения проблемы. Медицина и организация здравоохранения. 2019;2:4–12. URL: https://cyberleninka.ru/article/n/zabolevaniya-serdechno-sosudistoy-sistemy-kak-prichina-smertnosti-v-rossiyskoy-federatsii-puti-resheniya-problemy (date access: 13.12.2024).</mixed-citation><mixed-citation xml:lang="en">Ivanov D.O., Orel V.I., Alexandrovich Yu.S. and others. Diseases of the cardiovascular system as a cause of mortality in the Russian Federation: ways to solve the problem. Medicine and healthcare organization. 2019;2:4–12. (In Russian).  URL: https://cyberleninka.ru/article/n/zabolevaniya-serdechno-sosudistoy-sistemy-kak-prichina-smertnosti-v-rossiyskoy-federatsii-puti-resheniya-problemy (date access: 13.12.2024).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации МЗ РФ. Стабильная ишемическая болезнь сердца, 2024. Здравоохранение. Федеральная служба государственной статистики. URL: https://rosstat.gov.ru/folder/13721# (дата обращения: 13.12.2024).</mixed-citation><mixed-citation xml:lang="en">Clinical recommendations of the Ministry of Health of the Russian Federation. Stable coronary artery disease, 2024. Healthcare. Federal State Statistics Service. (In Russian). URL: https://rosstat.gov.ru/folder/13721# (date access: 13.12.2024).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А., Шальнова С.А., Деев А.Д. Смертность от сердечнососудистых заболеваний в Российской Федерации и возможные механизмы ее изменения. Журнал неврологии и психиатрии. 2018;8:98–103.</mixed-citation><mixed-citation xml:lang="en">Boytsov S.A.., Shalnova S.A.., Deev A.D. Mortality from cardiovascular diseases in the Russian Federation and possible mechanisms of its change. Journal of Neurology and Psychiatry. 2018;8:98–103. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Liu Y., Yang X., Li C., Song Z. The oral microbiota: community composition, influencing factors, pathogenesis, and interventions. Front Microbiol. 2022;13:895537. DOI: 10.3389/fmicb.2022.895537</mixed-citation><mixed-citation xml:lang="en">Li X., Liu Y., Yang X., Li C., Song Z. The oral microbiota: community composition, influencing factors, pathogenesis, and interventions. Front Microbiol. 2022;13:895537. DOI: 10.3389/fmicb.2022.895537</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Побожьева Л.В., Скворцов-Игралов Г.А., Бочарова Ю.А., Копецкий И.С., Чеботарь И.В. Взаимосвязь между бактериямиэпибионтами Nanosynbacter lyticus и воспалительными заболеваниями пародонта. Вестник РГМУ. 2024;6:139–143. DOI: 10.24075/vrgmu.2024.050</mixed-citation><mixed-citation xml:lang="en">Pobozhyeva L.V., Skvortsov-Iglov G.A., Bocharova Yu.A., Kopetsky I.S., Chebotar I.V. The relationship between Nanosynbacter lyticus epibiont bacteria and inflammatory periodontal diseases. Bulletin of the Russian State Medical University. 2024;6:139–143. (In Russian). DOI: 10.24075/vrgmu.2024.050</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Roth C.E., Craveiro R.B., Niederau C., Malyaran H., Neuss S., Jankowski J., et al. Mechanical compression by simulating orthodontic tooth movement in an in vitro model modulates phosphorylation of AKT and MAPKS via TLR4 in human periodontal ligament cells. Int. J. Mol. Sci. 2022;23(15):8062. DOI: https://doi.org/10.3390/ijms23158062</mixed-citation><mixed-citation xml:lang="en">Roth C.E., Craveiro R.B., Niederau C., Malyaran H., Neuss S., Jankowski J., et al. Mechanical compression by simulating orthodontic tooth movement in an in vitro model modulates phosphorylation of AKT and MAPKS via TLR4 in human periodontal ligament cells. Int. J. Mol. Sci. 2022;23(15):8062. DOI: https://doi.org/10.3390/ijms23158062</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Popova C., Dosseva-Panova V., Panov V. Microbiology of periodontal diseases. A review.Biotechnol. Biotechnol. Equip. 2013;27(3):3754–9. DOI: 10.5504/bbeq.2013.0027</mixed-citation><mixed-citation xml:lang="en">Popova C., Dosseva-Panova V., Panov V. Microbiology of periodontal diseases. A review.Biotechnol. Biotechnol. Equip. 2013;27(3):3754–9. DOI: 10.5504/bbeq.2013.0027</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Neal TW., Schlieve T. Complications of Severe Odontogenic Infections: A Review. Biology (Basel). 2022;11(12):1784. DOI: 10.3390/biology11121784. PMID: 36552293</mixed-citation><mixed-citation xml:lang="en">Neal TW., Schlieve T. Complications of Severe Odontogenic Infections: A Review. Biology (Basel). 2022;11(12):1784. DOI: 10.3390/biology11121784. PMID: 36552293</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jafarzadeh S.R., Thomas B.S., Warren D.K., Gill J., Fraser V.J. Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events. Clin. Infect. Dis. 2016;63(4):495–500. DOI: 10.1093/cid/ciw320</mixed-citation><mixed-citation xml:lang="en">Jafarzadeh S.R., Thomas B.S., Warren D.K., Gill J., Fraser V.J. Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events. Clin. Infect. Dis. 2016;63(4):495–500. DOI: 10.1093/cid/ciw320</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации МЗ РФ. Инфекционный эндокардит. 2021. URL: https://cr.minzdrav.gov.ru/recomend/54?ysclid=m-4rju8mpb2228587281 (дата обращения: 17.12.2024).</mixed-citation><mixed-citation xml:lang="en">Clinical recommendations of the Ministry of Health of the Russian Federation. Infectious endocarditis. 2021. (In Russian). URL: https://cr.minzdrav.gov.ru/recomend/54?ysclid=m4rju8mpb2228587281 (date access: 17.12.2024)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lindholm M., Metsäniitty M., Granström E., Oscarsson J. Outer membrane vesicle-mediated serum protection in Aggregatibacter actinomycetemcomitans. J. Oral Microbiol. 2020;12(1):1747857. DOI: 10.1080/20002297.2020.1747857</mixed-citation><mixed-citation xml:lang="en">Lindholm M., Metsäniitty M., Granström E., Oscarsson J. Outer membrane vesicle-mediated serum protection in Aggregatibacter actinomycetemcomitans. J. Oral Microbiol. 2020;12(1):1747857. DOI: 10.1080/20002297.2020.1747857</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ozuna H., Snider I., Belibasakis G.N., Oscarsson J., Johansson A., Uriarte S.M. Aggregatibacter actinomycetemcomitans and filifactor alocis: Two exotoxin- producing oral pathogens. Front Oral Health. 2022;3:981343. DOI: 10.3389/froh.2022.981343</mixed-citation><mixed-citation xml:lang="en">Ozuna H., Snider I., Belibasakis G.N., Oscarsson J., Johansson A., Uriarte S.M. Aggregatibacter actinomycetemcomitans and filifactor alocis: Two exotoxin- producing oral pathogens. Front Oral Health. 2022;3:981343. DOI: 10.3389/froh.2022.981343</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kobsar A., Wiebecke S., Weber K., Koessler A., Kuhn S., Boeck M. et al. Effect of toxins from different periodontitis-associated bacteria on human platelet function. Mol. Oral Microbiol. 2024;39(6):468–476. DOI: 10.1111/omi.12480</mixed-citation><mixed-citation xml:lang="en">Kobsar A., Wiebecke S., Weber K., Koessler A., Kuhn S., Boeck M. et al. Effect of toxins from different periodontitis-associated bacteria on human platelet function. Mol. Oral Microbiol. 2024;39(6):468–476. DOI: 10.1111/omi.12480</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Oscarsson J., Claesson R., Bao K., Brundin M., Belibasakis G.N. Phylogenetic analysis of filifactor alocis strains isolated from several oral infections identified a novel RTX toxin., FtxA. Toxins (Basel). 2020;12(11):687. DOI: 10.3390/toxins12110687</mixed-citation><mixed-citation xml:lang="en">Oscarsson J., Claesson R., Bao K., Brundin M., Belibasakis G.N. Phylogenetic analysis of filifactor alocis strains isolated from several oral infections identified a novel RTX toxin., FtxA. Toxins (Basel). 2020;12(11):687. DOI: 10.3390/toxins12110687</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Talapko J., Juzbašić M., Meštrović T., Matijević T., Mesarić D., Katalinić D.et al. Aggregatibacter actinomycetemcomitans: from the oral cavity to the heart valves. Microorganisms. 2024;12(7):1451. DOI: 10.3390/microorganisms12071451</mixed-citation><mixed-citation xml:lang="en">Talapko J., Juzbašić M., Meštrović T., Matijević T., Mesarić D., Katalinić D.et al. Aggregatibacter actinomycetemcomitans: from the oral cavity to the heart valves. Microorganisms. 2024;12(7):1451. DOI: 10.3390/microorganisms12071451</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wang C.Y., Wang H.C., Li J.M., Wang J.Y., Yang K.C., Ho Y.K. et al. Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Microbiol. Immunol. Infect. 2010;43(6):491–7. DOI: 10.1016/S1684-1182(10)60076-X</mixed-citation><mixed-citation xml:lang="en">Wang C.Y., Wang H.C., Li J.M., Wang J.Y., Yang K.C., Ho Y.K. et al. Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Microbiol. Immunol. Infect. 2010;43(6):491–7. DOI: 10.1016/S1684-1182(10)60076-X</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Borcan A.M., Olariu M.C., Costea E.L., Radu G., Simoiu M. Aggregatibacter actinomycetemcomitansendocarditis in an adult patient with patent ductus arteriosus. Germs. 2024;14(2):210–215. DOI: 10.18683/germs.2024.1433</mixed-citation><mixed-citation xml:lang="en">Borcan A.M., Olariu M.C., Costea E.L., Radu G., Simoiu M. Aggregatibacter actinomycetemcomitansendocarditis in an adult patient with patent ductus arteriosus. Germs. 2024;14(2):210–215. DOI: 10.18683/germs.2024.1433</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Oliveira F.A.F., Forte C.P.F., Silva P.G.B., Lopes C.B., Montenegro R.C., Santos Â.K.C.R.D. et al. Molecular analysis of oral bacteria in heart valve of patients with cardiovascular disease by real-time polymerase chain reaction. Medicine (Baltimore). 2015;94(47):e2067. DOI: 10.1097/MD.0000000000002067</mixed-citation><mixed-citation xml:lang="en">Oliveira F.A.F., Forte C.P.F., Silva P.G.B., Lopes C.B., Montenegro R.C., Santos Â.K.C.R.D. et al. Molecular analysis of oral bacteria in heart valve of patients with cardiovascular disease by real-time polymerase chain reaction. Medicine (Baltimore). 2015;94(47):e2067. DOI: 10.1097/MD.0000000000002067</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Del Giudice C., Vaia E., Liccardo D., Marzano F., Valletta A., Spagnuolo G. et al. Infective endocarditis: a focus on oral microbiota. Microorganisms. 2021;9(6):1218. DOI: 10.3390/microorganisms9061218</mixed-citation><mixed-citation xml:lang="en">Del Giudice C., Vaia E., Liccardo D., Marzano F., Valletta A., Spagnuolo G. et al. Infective endocarditis: a focus on oral microbiota. Microorganisms. 2021;9(6):1218. DOI: 10.3390/microorganisms9061218</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Liesenborghs L., Meyers S., Lox M., Criel M., Claes J., Peetermans M. et al. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves. Eur. Heart J. 2019;40(39):3248–3259. DOI: 10.1093/eurheartj/ehz175</mixed-citation><mixed-citation xml:lang="en">Liesenborghs L., Meyers S., Lox M., Criel M., Claes J., Peetermans M. et al. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves. Eur. Heart J. 2019;40(39):3248–3259. DOI: 10.1093/eurheartj/ehz175</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yasir A., Ghaidaa Gihadi Mohammed. (2024). THE importance of microRNAs in Endocarditis Associated with Staphylococcus aureus. University of Thi-Qar Journal of Science. 2024;11(2):34–39. DOI: 10.32792/utq/utjsci/v11i2.1226</mixed-citation><mixed-citation xml:lang="en">Yasir A., Ghaidaa Gihadi Mohammed. (2024). THE importance of microRNAs in Endocarditis Associated with Staphylococcus aureus. University of Thi-Qar Journal of Science. 2024;11(2):34–39. DOI: 10.32792/utq/utjsci/v11i2.1226</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Martini A.M., Moricz B.S., Ripperger A.K., Tran P.M., Sharp M.E., Forsythe A.N. et al. Association of Novel Streptococcus sanguinis virulence factors with pathogenesis in a native valve infective endocarditis model. Front Microbiol. 2020;11:10. DOI: 10.3389/fmicb.2020.00010</mixed-citation><mixed-citation xml:lang="en">Martini A.M., Moricz B.S., Ripperger A.K., Tran P.M., Sharp M.E., Forsythe A.N. et al. Association of Novel Streptococcus sanguinis virulence factors with pathogenesis in a native valve infective endocarditis model. Front Microbiol. 2020;11:10. DOI: 10.3389/fmicb.2020.00010</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Souto R., Colombo AP. Prevalence of Enterococcus faecalis in subgingival biofilm and saliva of subjects with chronic periodontal infection. Arch. Oral Biol. 2008;53(2):155–60. DOI: 10.1016/j.archoralbio.2007.08.004</mixed-citation><mixed-citation xml:lang="en">Souto R., Colombo AP. Prevalence of Enterococcus faecalis in subgingival biofilm and saliva of subjects with chronic periodontal infection. Arch. Oral Biol. 2008;53(2):155–60. DOI: 10.1016/j.archoralbio.2007.08.004</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Dahl A., Iversen K., Tonder N., Hoest N., Arpi M., Dalsgaard M.et al. Prevalence of infective endocarditis in enterococcus faecalis bacteremia. J. Am. Coll. Cardiol. 2019;74(2):193–201. DOI: 10.1016/j.jacc.2019.04.059</mixed-citation><mixed-citation xml:lang="en">Dahl A., Iversen K., Tonder N., Hoest N., Arpi M., Dalsgaard M.et al. Prevalence of infective endocarditis in enterococcus faecalis bacteremia. J. Am. Coll. Cardiol. 2019;74(2):193–201. DOI: 10.1016/j.jacc.2019.04.059</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lockhart P.B., Brennan M.T., Sasser H.C., Fox P.C., Paster B.J., Bahrani-Mougeot F.K. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–25. DOI: 10.1161/CIRCULATIONAHA.107.758524</mixed-citation><mixed-citation xml:lang="en">Lockhart P.B., Brennan M.T., Sasser H.C., Fox P.C., Paster B.J., Bahrani-Mougeot F.K. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–25. DOI: 10.1161/CIRCULATIONAHA.107.758524</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mougeot F.K., Saunders S.E., Brennan M.T., Lockhart P.B. Associations between bacteremia from oral sources and distant-site infections: tooth brushing versus single tooth extraction. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015;119(4):430–5. DOI: 10.1016/j.oooo.2015.01.009</mixed-citation><mixed-citation xml:lang="en">Mougeot F.K., Saunders S.E., Brennan M.T., Lockhart P.B. Associations between bacteremia from oral sources and distant-site infections: tooth brushing versus single tooth extraction. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015;119(4):430–5. DOI: 10.1016/j.oooo.2015.01.009</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Tubiana S., Blotière P.O., Hoen B., Lesclous P., Millot S., Rudant J. et al. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017;358:j3776. DOI: 10.1136/bmj.j3776</mixed-citation><mixed-citation xml:lang="en">Tubiana S., Blotière P.O., Hoen B., Lesclous P., Millot S., Rudant J. et al. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017;358:j3776. DOI: 10.1136/bmj.j3776</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Инфекционный эндокардит и инфекции внутрисердечных устройств. Клинические рекомендации МЗ РФ., 2021. URL: https://scardio.ru/content/Guidelines/KP_Inf_Endokardit.pdf?ysclid=m6xxk987o7797865458 (дата обращения 09.02.2025).</mixed-citation><mixed-citation xml:lang="en">Infectious endocarditis and intracardiac device infections. Clinical recommendations of the Ministry of Health of the Russian Federation., 2021. (In Russian). URL: https://scardio.ru/content/Guidelines/KP_Inf_Endokardit.pdf?ysclid=m6xxk987o7797865458 (date access 09.02.2025).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Del Giudice C., Vaia E., Liccardo D., Marzano F., Valletta A., Spagnuolo G. et al. Infective endocarditis: a focus on oral microbiota. Microorganisms. 2021;9(6):1218. DOI: 10.3390/microorganisms9061218</mixed-citation><mixed-citation xml:lang="en">Del Giudice C., Vaia E., Liccardo D., Marzano F., Valletta A., Spagnuolo G. et al. Infective endocarditis: a focus on oral microbiota. Microorganisms. 2021;9(6):1218. DOI: 10.3390/microorganisms9061218</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">DeStefano F., Anda R.F., Kahn H.S., Williamson D.F., Russell C.M. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993;306(6879):688–91. DOI: 10.1136/bmj.306.6879.688</mixed-citation><mixed-citation xml:lang="en">DeStefano F., Anda R.F., Kahn H.S., Williamson D.F., Russell C.M. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993;306(6879):688–91. DOI: 10.1136/bmj.306.6879.688</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Humphrey L.L., Fu R., Buckley D.I., Freeman M., Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J. Gen. Intern. Med. 2008;23(12):2079– 86. DOI: 10.1007/s11606-008-0787-6</mixed-citation><mixed-citation xml:lang="en">Humphrey L.L., Fu R., Buckley D.I., Freeman M., Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J. Gen. Intern. Med. 2008;23(12):2079– 86. DOI: 10.1007/s11606-008-0787-6</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bouzid F., Gtif I., Alfadhli S., Charfeddine S., Ghorbel W., Abdelhédi R. et al. A potential oral microbiome signature associated with coronary artery disease in Tunisia. Biosci. Rep. 2022;42(7):BSR20220583. DOI: 10.1042/BSR20220583</mixed-citation><mixed-citation xml:lang="en">Bouzid F., Gtif I., Alfadhli S., Charfeddine S., Ghorbel W., Abdelhédi R. et al. A potential oral microbiome signature associated with coronary artery disease in Tunisia. Biosci. Rep. 2022;42(7):BSR20220583. DOI: 10.1042/BSR20220583</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yumoto H., Nakae H., Fujinaka K., Ebisu S., Matsuo T. Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens. Infect. Immun. 1999;67(1):384–94. DOI: 10.1128/IAI.67.1.384-394.1999</mixed-citation><mixed-citation xml:lang="en">Yumoto H., Nakae H., Fujinaka K., Ebisu S., Matsuo T. Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens. Infect. Immun. 1999;67(1):384–94. DOI: 10.1128/IAI.67.1.384-394.1999</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Viafara-Garcia S.M., Gualtero DF., Avila-Ceballos D., Lafaurie G.I. Eikenella corrodens lipopolysaccharide stimulates the pro-atherosclerotic response in human coronary artery endothelial cells and monocyte adhesion. Eur. J. Oral Sci. 2018;126(6):476–484. DOI: 10.1111/eos.12580</mixed-citation><mixed-citation xml:lang="en">Viafara-Garcia S.M., Gualtero DF., Avila-Ceballos D., Lafaurie G.I. Eikenella corrodens lipopolysaccharide stimulates the pro-atherosclerotic response in human coronary artery endothelial cells and monocyte adhesion. Eur. J. Oral Sci. 2018;126(6):476–484. DOI: 10.1111/eos.12580</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Chhibber-Goel J., Singhal V., Bhowmik D., Vivek R., Parakh N., Bhargava B., Sharma A. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilms Microbiomes. 2016;2:7. DOI: 10.1038/s41522-016-0009-7</mixed-citation><mixed-citation xml:lang="en">Chhibber-Goel J., Singhal V., Bhowmik D., Vivek R., Parakh N., Bhargava B., Sharma A. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilms Microbiomes. 2016;2:7. DOI: 10.1038/s41522-016-0009-7</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Schenkein H.A., Loos B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J. Clin. Periodontol. 2013;40 Suppl 14(0 14):S51–69. DOI: 10.1111/jcpe.12060</mixed-citation><mixed-citation xml:lang="en">Schenkein H.A., Loos B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J. Clin. Periodontol. 2013;40 Suppl 14(0 14):S51–69. DOI: 10.1111/jcpe.12060</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Liljestrand J.M., Paju S., Pietiäinen M., Buhlin K., Persson G.R., Nieminen M.S. et al. Immunologic burden links periodontitis to acute coronary syndrome. Atherosclerosis. 2018;268:177–184. DOI: 10.1016/j.atherosclerosis.2017.12.007</mixed-citation><mixed-citation xml:lang="en">Liljestrand J.M., Paju S., Pietiäinen M., Buhlin K., Persson G.R., Nieminen M.S. et al. Immunologic burden links periodontitis to acute coronary syndrome. Atherosclerosis. 2018;268:177–184. DOI: 10.1016/j.atherosclerosis.2017.12.007</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kesavalu L., Lucas A.R., Verma RK., Liu L., Dai E., Sampson E., Progulske-Fox A. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J. Dent. Res. 2012;91(3):255–60. DOI: 10.1177/0022034511435101</mixed-citation><mixed-citation xml:lang="en">Kesavalu L., Lucas A.R., Verma RK., Liu L., Dai E., Sampson E., Progulske-Fox A. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J. Dent. Res. 2012;91(3):255–60. DOI: 10.1177/0022034511435101</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Pietiäinen M., Liljestrand J.M., Kopra E., Pussinen P.J. Mediators between oral dysbiosis and cardiovascular diseases. Eur. J. Oral Sci. 2018;126(1):26–36. DOI: 10.1111/eos.12423. PMID: 30178551</mixed-citation><mixed-citation xml:lang="en">Pietiäinen M., Liljestrand J.M., Kopra E., Pussinen P.J. Mediators between oral dysbiosis and cardiovascular diseases. Eur. J. Oral Sci. 2018;126(1):26–36. DOI: 10.1111/eos.12423. PMID: 30178551</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sen S., Logue L., Logue M., Otersen E.A.L., Mason E., Moss K. et al. Dental caries, race and incident ischemic stroke, coronary heart disease and death. Stroke. 2024;55(1):40–49. DOI: 10.1161/STROKEAHA.123.042528</mixed-citation><mixed-citation xml:lang="en">Sen S., Logue L., Logue M., Otersen E.A.L., Mason E., Moss K. et al. Dental caries, race and incident ischemic stroke, coronary heart disease and death. Stroke. 2024;55(1):40–49. DOI: 10.1161/STROKEAHA.123.042528</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Кабурова А.Н., Драпкина О.М., Юдин С.М., Яфарова А.А., Корецкий С.Н., Покровская М.С. и др. Связь микробиоты кишечника с системным воспалением и эндотоксемией у пациентов с хронической сердечной недостаточностью и сохраненной фракцией выброса. Кардиоваскулярная терапия и профилактика. 2022;21(9):3315. DOI: 10.15829/1728-8800-2022-3315</mixed-citation><mixed-citation xml:lang="en">Kaburova A.N., Drapkina O.M., Yudin S.M., Yafarova A.A., Koretsky S.N., Pokrovskaya M.S. et al. The relationship between gut microbiota., chronic systemic inflammation., and endotoxemia in patients with heart failure with preserved ejection fraction. Cardiovascular Therapy and Prevention. 2022;21(9):3315. (In Russian) DOI: 10.15829/1728-8800-2022-3315</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Matacchione G., Piacenza F., Pimpini L., Rosati Y., Marcozzi S. The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging. Clin. Epigenetics. 2024;16(1):175. DOI: 10.1186/s13148-024-01786-9</mixed-citation><mixed-citation xml:lang="en">Matacchione G., Piacenza F., Pimpini L., Rosati Y., Marcozzi S. The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging. Clin. Epigenetics. 2024;16(1):175. DOI: 10.1186/s13148-024-01786-9</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 1990;323(4):236–41. DOI: 10.1056/NEJM199007263230405</mixed-citation><mixed-citation xml:lang="en">Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 1990;323(4):236–41. DOI: 10.1056/NEJM199007263230405</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Mann D.L. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ. Res. 2015;116(7):1254–68. DOI: 10.1161/CIRCRESAHA.116.302317</mixed-citation><mixed-citation xml:lang="en">Mann D.L. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ. Res. 2015;116(7):1254–68. DOI: 10.1161/CIRCRESAHA.116.302317</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L., Wang Y., Cao Z.Y., Wang M.M., Liu X.M., Gao T. et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after longterm myocardial infarction. J. Cell. Mol. Med. 2015;19(12):2728–40. DOI: 10.1111/jcmm.12659</mixed-citation><mixed-citation xml:lang="en">Liu L., Wang Y., Cao Z.Y., Wang M.M., Liu X.M., Gao T. et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after longterm myocardial infarction. J. Cell. Mol. Med. 2015;19(12):2728–40. DOI: 10.1111/jcmm.12659</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Francisqueti-Ferron F.V., Nakandakare-Maia E.T., Siqueira J.S., Ferron A.J.T., Vieira T.A., Bazan S.G.Z., Corrêa C.R. The role of gut dysbiosis-associated inflammation in heart failure. Rev. Assoc. Med. Bras. 2022;68(8):1120–1124. DOI: 10.1590/1806-9282.20220197</mixed-citation><mixed-citation xml:lang="en">Francisqueti-Ferron F.V., Nakandakare-Maia E.T., Siqueira J.S., Ferron A.J.T., Vieira T.A., Bazan S.G.Z., Corrêa C.R. The role of gut dysbiosis-associated inflammation in heart failure. Rev. Assoc. Med. Bras. 2022;68(8):1120–1124. DOI: 10.1590/1806-9282.20220197</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Mills KT., Stefanescu A., He J. The global epidemiology of hypertension. Nat. Rev. Nephrol. 2020;16(4):223–237. DOI: 10.1038/s41581-019-0244-2</mixed-citation><mixed-citation xml:lang="en">Mills KT., Stefanescu A., He J. The global epidemiology of hypertension. Nat. Rev. Nephrol. 2020;16(4):223–237. DOI: 10.1038/s41581-019-0244-2</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Баланова Ю.А., Драпкина О.М., Куценко В.А., Имаева А.Э., Концевая М.В., Максимов С.А., и др. Артериальная гипертония в российской популяции в период пандемии COVID-19: гендерные различия в распространённости, лечении и его эффективности. Данные исследования ЭССЕ-РФ3. Кардиоваскулярная терапия и профилактика. 2023;22(8S):3785. . DOI: 10.15829/1728-8800-2023-3785. EDN: YRUNUX</mixed-citation><mixed-citation xml:lang="en">Balanova Yu.A., Drapkina O.M., Kutsenko V.A., Imaeva A.E., Kontseva M.V., Maksimov S.A. et al. Arterial hypertension in the Russian population during the COVID-19 pandemic: gender differences in prevalence, treatment and its effectiveness. The ESSAY research data is RF3. Cardiovascular therapy and prevention. 2023;22(8S):3785. (in Russian). DOI: 10.15829/1728-8800-2023-3785. EDN: YRUNUX</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">d’El-Rei J., Cunha AR., Trindade M., Neves MF. Beneficial effects of dietary nitrate on endothelial function and blood pressure levels. Int. J. Hypertens. 2016;2016:6791519. DOI: 10.1155/2016/6791519</mixed-citation><mixed-citation xml:lang="en">d’El-Rei J., Cunha AR., Trindade M., Neves MF. Beneficial effects of dietary nitrate on endothelial function and blood pressure levels. Int. J. Hypertens. 2016;2016:6791519. DOI: 10.1155/2016/6791519</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Velmurugan S., Gan J.M., Rathod K.S., Khambata R.S., Ghosh S.M., Hartley A.et al. Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized., double-blind., placebo-controlled study. Am. J. Clin. Nutr. 2016;103(1):25–38. DOI: 10.3945/ajcn.115.116244. Erratum in: Am. J. Clin. Nutr. 2018;107(4):676. DOI: 10.1093/ajcn/nqx052</mixed-citation><mixed-citation xml:lang="en">Velmurugan S., Gan J.M., Rathod K.S., Khambata R.S., Ghosh S.M., Hartley A.et al. Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized., double-blind., placebo-controlled study. Am. J. Clin. Nutr. 2016;103(1):25–38. DOI: 10.3945/ajcn.115.116244. Erratum in: Am. J. Clin. Nutr. 2018;107(4):676. DOI: 10.1093/ajcn/nqx052</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Lidder S., Webb A.J. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br. J. Clin. Pharmacol. 2013;75(3):677–96. DOI: 10.1111/j.1365-2125.2012.04420.x</mixed-citation><mixed-citation xml:lang="en">Lidder S., Webb A.J. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br. J. Clin. Pharmacol. 2013;75(3):677–96. DOI: 10.1111/j.1365-2125.2012.04420.x</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Bondonno C.P., Liu A.H., Croft K.D., Considine M.J., Puddey I.B., Woodman R.J., Hodgson J.M. Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women. Am. J. Hypertens. 2015;28(5):572–5. DOI: 10.1093/ajh/hpu192. Epub 2014 Oct 30. PMID: 25359409</mixed-citation><mixed-citation xml:lang="en">Bondonno C.P., Liu A.H., Croft K.D., Considine M.J., Puddey I.B., Woodman R.J., Hodgson J.M. Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women. Am. J. Hypertens. 2015;28(5):572–5. DOI: 10.1093/ajh/hpu192. Epub 2014 Oct 30. PMID: 25359409</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Mitsui T., Harasawa R. The effects of essential oil., povidone-iodine., and chlorhexidine mouthwash on salivary nitrate/nitrite and nitrate-reducing bacteria. J. Oral Sci. 2017;59(4):597–601. DOI: 10.2334/josnusd.16-0593</mixed-citation><mixed-citation xml:lang="en">Mitsui T., Harasawa R. The effects of essential oil., povidone-iodine., and chlorhexidine mouthwash on salivary nitrate/nitrite and nitrate-reducing bacteria. J. Oral Sci. 2017;59(4):597–601. DOI: 10.2334/josnusd.16-0593</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Ostalska-Nowicka D., Paszyńska E., Dmitrzak-Węglarz M., Neyman-Bartkowiak A., Rabiega A., Zachwieja J., Nowicki M. Dental caries-related primary hypertension in children and adolescents: Cross-sectional study. Oral Dis. 2021;27(7):1822–1833. DOI: 10.1111/odi.13700</mixed-citation><mixed-citation xml:lang="en">Ostalska-Nowicka D., Paszyńska E., Dmitrzak-Węglarz M., Neyman-Bartkowiak A., Rabiega A., Zachwieja J., Nowicki M. Dental caries-related primary hypertension in children and adolescents: Cross-sectional study. Oral Dis. 2021;27(7):1822–1833. DOI: 10.1111/odi.13700</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Колесникова Л.Р., Долгих В.В., Колесникова Л.И., Власов Б.Я., Натяганова К. Взаимосвязь артериальной гипертензии и степени активности кариозного процесса у детей. Стоматология. 2016;95(2):26–29. DOI: 10.17116/stomat201695226-29</mixed-citation><mixed-citation xml:lang="en">Kolesnikova LR., Dolgikh VV., Kolesnikova LI., Vlasov BYa., Natyaganova LV. The impact of arterial hypertension in children on dental decay activity. Stomatology. 2016;95(2):26–29. (In Russian). DOI: 10.17116/stomat201695226-29</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Deehan EC., Yang C., Perez-Muñoz M.E., Nguyen N.K., Cheng C.C., Triador L.et al. Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell. Host Microbe. 2020;27(3):389–404.e6. DOI: 10.1016/j.chom.2020.01.006</mixed-citation><mixed-citation xml:lang="en">Deehan EC., Yang C., Perez-Muñoz M.E., Nguyen N.K., Cheng C.C., Triador L.et al. Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell. Host Microbe. 2020;27(3):389–404.e6. DOI: 10.1016/j.chom.2020.01.006</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang S.M., Huang S.L. The commensal anaerobe veillonella dispar reprograms its lactate metabolism and short-chain fatty acid production during the stationary phase. Microbiol. Spectr. 2023;11(2):e0355822. DOI: 10.1128/spectrum.03558-22</mixed-citation><mixed-citation xml:lang="en">Zhang S.M., Huang S.L. The commensal anaerobe veillonella dispar reprograms its lactate metabolism and short-chain fatty acid production during the stationary phase. Microbiol. Spectr. 2023;11(2):e0355822. DOI: 10.1128/spectrum.03558-22</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Perry R.J., Peng L., Barry N.A., Cline G.W., Zhang D., Cardone R.L. et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature. 2016;534(7606):213–7. DOI: 10.1038/nature18309</mixed-citation><mixed-citation xml:lang="en">Perry R.J., Peng L., Barry N.A., Cline G.W., Zhang D., Cardone R.L. et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature. 2016;534(7606):213–7. DOI: 10.1038/nature18309</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Zhao F., Wang Y., Chen J., Tao J., Tian G. et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. DOI: 10.1186/s40168-016-0222-x</mixed-citation><mixed-citation xml:lang="en">Li J., Zhao F., Wang Y., Chen J., Tao J., Tian G. et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. DOI: 10.1186/s40168-016-0222-x</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Яковлева М.В., Червинец В.М., Червинец Ю.В., Смирнова Л.Е. Микробиота кишечника и полости рта у больных артериальной гипертензией с метаболическим синдромом. Патологическая физиология и экспериментальная терапия. 2020;64(4):101–105. DOI: 10.25557/0031-2991.2020.04.101-105</mixed-citation><mixed-citation xml:lang="en">Yakovleva M.V., Chervinets V.M., Chervinets Yu.V., Smirnova L.E. Gut and oral microbiota in patients with arterial hypertension and metabolic syndrome. Patologicheskaya Fiziologiya i Eksperimental`naya terapiya. (Pathological Physiology and Experimental Therapy., Russian Journal). 2020;64(4):101–105. (In Russian). DOI: 10.25557/0031-2991.2020.04.101-105</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Sintim H.O., Gürsoy U.K. Biofilms as “Connectors” for Oral and Systems Medicine: A New Opportunity for Biomarkers., Molecular Targets., and Bacterial Eradication. OMICS. 2016;20(1):3–11. DOI: 10.1089/omi.2015.0146</mixed-citation><mixed-citation xml:lang="en">Sintim H.O., Gürsoy U.K. Biofilms as “Connectors” for Oral and Systems Medicine: A New Opportunity for Biomarkers., Molecular Targets., and Bacterial Eradication. OMICS. 2016;20(1):3–11. DOI: 10.1089/omi.2015.0146</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Olsen I., Hajishengallis G. Major neutrophil functions subverted by Porphyromonas gingivalis. J. Oral Microbiol. 2016;8:30936. DOI: 10.3402/jom.v8.30936</mixed-citation><mixed-citation xml:lang="en">Olsen I., Hajishengallis G. Major neutrophil functions subverted by Porphyromonas gingivalis. J. Oral Microbiol. 2016;8:30936. DOI: 10.3402/jom.v8.30936</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010;8(7):481–90. DOI: 10.1038/nrmicro2337</mixed-citation><mixed-citation xml:lang="en">Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010;8(7):481–90. DOI: 10.1038/nrmicro2337</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Hajishengallis E., Hajishengallis G. Neutrophil homeostasis and periodontal health in children and adults. J. Dent. Res. 2014;93(3):231-7. DOI: 10.1177/0022034513507956</mixed-citation><mixed-citation xml:lang="en">Hajishengallis E., Hajishengallis G. Neutrophil homeostasis and periodontal health in children and adults. J. Dent. Res. 2014;93(3):231-7. DOI: 10.1177/0022034513507956</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Hajishengallis G., Harokopakis E. Porphyromonas gingivalis interactions with complement receptor 3 (CR3): innate immunity or immune evasion? Front Biosci. 2007;12:4547–57. DOI: 10.2741/2409</mixed-citation><mixed-citation xml:lang="en">Hajishengallis G., Harokopakis E. Porphyromonas gingivalis interactions with complement receptor 3 (CR3): innate immunity or immune evasion? Front Biosci. 2007;12:4547–57. DOI: 10.2741/2409</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Hajishengallis G., Shakhatreh MA., Wang M., Liang S. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J. Immunol. 2007;179(4):2359–67. DOI: 10.4049/jimmunol.179.4.2359</mixed-citation><mixed-citation xml:lang="en">Hajishengallis G., Shakhatreh MA., Wang M., Liang S. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J. Immunol. 2007;179(4):2359–67. DOI: 10.4049/jimmunol.179.4.2359</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Imamura T., Potempa J., Tanase S., Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J. Biol. Chem. 1997;272(25):16062–7. DOI: 10.1074/jbc.272.25.16062</mixed-citation><mixed-citation xml:lang="en">Imamura T., Potempa J., Tanase S., Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J. Biol. Chem. 1997;272(25):16062–7. DOI: 10.1074/jbc.272.25.16062</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Tonelli A., Lumngwena EN., Ntusi NAB. The oral microbiome in the pathophysiology of cardiovascular disease. Nat. Rev. Cardiol. 2023;20(6):386–403. DOI: 10.1038/s41569-022-00825-3</mixed-citation><mixed-citation xml:lang="en">Tonelli A., Lumngwena EN., Ntusi NAB. The oral microbiome in the pathophysiology of cardiovascular disease. Nat. Rev. Cardiol. 2023;20(6):386–403. DOI: 10.1038/s41569-022-00825-3</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Neves A.L., Coelho J., Couto L., Leite-Moreira A., Roncon-Albuquerque R.Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J. Mol. Endocrinol. 2013;51(2):R51–64. DOI: 10.1530/JME-13-0079</mixed-citation><mixed-citation xml:lang="en">Neves A.L., Coelho J., Couto L., Leite-Moreira A., Roncon-Albuquerque R.Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J. Mol. Endocrinol. 2013;51(2):R51–64. DOI: 10.1530/JME-13-0079</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Liljestrand J.M., Paju S., Pietiäinen M., Buhlin K., Persson G.R., Nieminen M.S.et al. Immunologic burden links periodontitis to acute coronary syndrome. Atherosclerosis. 2018;268:177–184. DOI: 10.1016/j.atherosclerosis.2017.12.007</mixed-citation><mixed-citation xml:lang="en">Liljestrand J.M., Paju S., Pietiäinen M., Buhlin K., Persson G.R., Nieminen M.S.et al. Immunologic burden links periodontitis to acute coronary syndrome. Atherosclerosis. 2018;268:177–184. DOI: 10.1016/j.atherosclerosis.2017.12.007</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Jia R., Kurita-Ochiai T., Oguchi S., Yamamoto M. Periodontal pathogen accelerates lipid peroxidation and atherosclerosis. J. Dent. Res. 2013;92(3):247–52. DOI: 10.1177/0022034513475625</mixed-citation><mixed-citation xml:lang="en">Jia R., Kurita-Ochiai T., Oguchi S., Yamamoto M. Periodontal pathogen accelerates lipid peroxidation and atherosclerosis. J. Dent. Res. 2013;92(3):247–52. DOI: 10.1177/0022034513475625</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Tuomainen AM., Jauhiainen M., Kovanen PT., Metso J., Paju S., Pussinen PJ. Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb. Pathog. 2008;44(2):111–7. DOI: 10.1016/j.micpath.2007.08.011</mixed-citation><mixed-citation xml:lang="en">Tuomainen AM., Jauhiainen M., Kovanen PT., Metso J., Paju S., Pussinen PJ. Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb. Pathog. 2008;44(2):111–7. DOI: 10.1016/j.micpath.2007.08.011</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Tonetti M.S., D’Aiuto F., Nibali L., Donald A., Storry C., Parkar M. et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 2007;356(9):911–20. DOI: 10.1056/NEJMoa063186. Erratum in: N. Engl. J. Med. 2018;378(25):2450. DOI: 10.1056/NEJMx180022</mixed-citation><mixed-citation xml:lang="en">Tonetti M.S., D’Aiuto F., Nibali L., Donald A., Storry C., Parkar M. et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 2007;356(9):911–20. DOI: 10.1056/NEJMoa063186. Erratum in: N. Engl. J. Med. 2018;378(25):2450. DOI: 10.1056/NEJMx180022</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Mollenhauer J., Schulmeister A. The humoral immune response to heat shock proteins. Experientia. 1992;48(7):644–9. DOI: 10.1007/BF02118310</mixed-citation><mixed-citation xml:lang="en">Mollenhauer J., Schulmeister A. The humoral immune response to heat shock proteins. Experientia. 1992;48(7):644–9. DOI: 10.1007/BF02118310</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Suárez LJ., Garzón H., Arboleda S., Rodríguez A. Oral Dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A Review. Front Immunol. 2020;11:591255. DOI: 10.3389/fimmu.2020.591255</mixed-citation><mixed-citation xml:lang="en">Suárez LJ., Garzón H., Arboleda S., Rodríguez A. Oral Dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A Review. Front Immunol. 2020;11:591255. DOI: 10.3389/fimmu.2020.591255</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Wick G., Perschinka H., Xu Q. Autoimmunity and atherosclerosis. am. Heart J. 1999;138(5 Pt 2):S444–9. DOI: 10.1016/s0002-8703(99)70272-3</mixed-citation><mixed-citation xml:lang="en">Wick G., Perschinka H., Xu Q. Autoimmunity and atherosclerosiS. am. Heart J. 1999;138(5 Pt 2):S444–9. DOI: 10.1016/s0002-8703(99)70272-3</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Wick G., Jakic B., Buszko M., Wick MC., Grundtman C. The role of heat shock proteins in atherosclerosis. Nat. Rev. Cardiol. 2014;11(9):516–29. DOI: 10.1038/nrcardio.2014.91</mixed-citation><mixed-citation xml:lang="en">Wick G., Jakic B., Buszko M., Wick MC., Grundtman C. The role of heat shock proteins in atherosclerosis. Nat. Rev. Cardiol. 2014;11(9):516–29. DOI: 10.1038/nrcardio.2014.91</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Kilian M. The oral microbiome - friend or foe? Eur. J. Oral Sci. 2018;126(1):5–12. DOI: 10.1111/eos.12527</mixed-citation><mixed-citation xml:lang="en">Kilian M. The oral microbiome - friend or foe? Eur. J. Oral Sci. 2018;126(1):5–12. DOI: 10.1111/eos.12527</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Sälzer S., Graetz C., Dörfer C.E., Slot D.E., Van der Weijden F.A. Contemporary practices for mechanical oral hygiene to prevent periodontal disease. Periodontol. 2000. 2020;84(1):35–44. DOI: 10.1111/prd.12332</mixed-citation><mixed-citation xml:lang="en">Sälzer S., Graetz C., Dörfer C.E., Slot D.E., Van der Weijden F.A. Contemporary practices for mechanical oral hygiene to prevent periodontal disease. Periodontol. 2000. 2020;84(1):35–44. DOI: 10.1111/prd.12332</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Chapple I.L., Van der Weijden F., Doerfer C., Herrera D., Shapira L., Polak D. et al. Primary prevention of periodontitis: managing gingivitis. J. Clin. Periodontol. 2015;42(16):S71–6. DOI: 10.1111/jcpe.12366</mixed-citation><mixed-citation xml:lang="en">Chapple I.L., Van der Weijden F., Doerfer C., Herrera D., Shapira L., Polak D. et al. Primary prevention of periodontitis: managing gingivitis. J. Clin. Periodontol. 2015;42(16):S71–6. DOI: 10.1111/jcpe.12366</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Arnett D.K., Blumenthal R.S., Albert M.A., Buroker A.B., Goldberger Z.D., Hahn E.J. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563–e595. DOI: 10.1161/CIR.0000000000000677. Erratum in: Circulation. 2019;140(11):e647–e648. Erratum in: Circulation. 2020 Jan 28;141(4):e59. Erratum in: Circulation. 2020;141(16):e773</mixed-citation><mixed-citation xml:lang="en">Arnett D.K., Blumenthal R.S., Albert M.A., Buroker A.B., Goldberger Z.D., Hahn E.J. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563–e595. DOI: 10.1161/CIR.0000000000000677. Erratum in: Circulation. 2019;140(11):e647–e648. Erratum in: Circulation. 2020 Jan 28;141(4):e59. Erratum in: Circulation. 2020;141(16):e773</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Jia YJ., Liao Y., He Y.Q., Zheng M.Q., Tong X.T., Xue W.Q. et al. Association between oral microbiota and cigarette smoking in the chinese population. Front. Cell Infect. Microbiol. 2021;11:658203. DOI: 10.3389/fcimb.2021.658203</mixed-citation><mixed-citation xml:lang="en">Jia YJ., Liao Y., He Y.Q., Zheng M.Q., Tong X.T., Xue W.Q. et al. Association between oral microbiota and cigarette smoking in the chinese population. Front. Cell Infect. Microbiol. 2021;11:658203. DOI: 10.3389/fcimb.2021.658203</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Beklen A., Sali N., Yavuz M.B. The impact of smoking on periodontal status and dental caries. Tob. Induc. Dis. 2022;20:72. DOI: 10.18332/tid/152112</mixed-citation><mixed-citation xml:lang="en">Beklen A., Sali N., Yavuz M.B. The impact of smoking on periodontal status and dental caries. Tob. Induc. Dis. 2022;20:72. DOI: 10.18332/tid/152112</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Bergström J. Tobacco smoking and chronic destructive periodontal disease. Odontology. 2004;92(1):1–8. DOI: 10.1007/s10266-004-0043-4</mixed-citation><mixed-citation xml:lang="en">Bergström J. Tobacco smoking and chronic destructive periodontal disease. Odontology. 2004;92(1):1–8. DOI: 10.1007/s10266-004-0043-4</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Tobacco: Preventing Uptake, Promoting Quitting and Treating Dependence. 2023.</mixed-citation><mixed-citation xml:lang="en">Tobacco: Preventing Uptake, Promoting Quitting and Treating Dependence. 2023.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Benowitz N.L., Barua R.S., Rigotti N.A. et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology task force on clinical expert consensus documents J. Am. Coll. Cardiol. 2018;72(25): 3332–3365. DOI: https://doi.org/10.1016/j.jacc.2018.10.027</mixed-citation><mixed-citation xml:lang="en">Benowitz N.L., Barua R.S., Rigotti N.A. et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology task force on clinical expert consensus documents J. Am. Coll. Cardiol. 2018;72(25): 3332–3365. DOI: https://doi.org/10.1016/j.jacc.2018.10.027</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Royal College of Physicians. E-Cigarettes and Harm Reduction: An Evidence Review. RCP, 2024.</mixed-citation><mixed-citation xml:lang="en">Royal College of Physicians. E-Cigarettes and Harm Reduction: An Evidence Review. RCP, 2024.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Visseren F.L.J., Mach F., Smulders Y.M., Carballo D. et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021; 42(34): 3227–3337. DOI: https://doi.org/10.1093/eurheartj/ehab484 Erratum in: Eur. Heart J. 2022; 43(42): 4468.</mixed-citation><mixed-citation xml:lang="en">Visseren F.L.J., Mach F., Smulders Y.M., Carballo D. et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021; 42(34): 3227–3337. DOI: https://doi.org/10.1093/eurheartj/ehab484 Erratum in: Eur. Heart J. 2022; 43(42): 4468.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Mostaza J.M., Pintó X., Armario P., Masana L. et al. SEA 2024 standards for global control of vascular risk. Clin. Investig. Arterioscler. 2024; 36(3);133–194. DOI: https://doi.org/10.1016/j.arteri.2024.02.001 (in English, Spanish).</mixed-citation><mixed-citation xml:lang="en">Mostaza J.M., Pintó X., Armario P., Masana L. et al. SEA 2024 standards for global control of vascular risk. Clin. Investig. Arterioscler. 2024; 36(3);133–194. DOI: https://doi.org/10.1016/j.arteri.2024.02.001 (in English, Spanish).</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Abellán Alemán J., Sabaris R.C., Pardo D.E., García Donaire J.A. et al. En representación de la Sociedad Española de Hipertensión y las Sociedades Autonómicas de Hipertensión y Riesgo Vascular de España. Documento de consenso sobre tabaquismo y riesgo vascular. Hipertens. Riesgo Vasc. 2024; 41(suppl. 1);S1–S85. DOI: https://doi.org/10.1016/S1889-1837(24)00075-8 (in Spanish).</mixed-citation><mixed-citation xml:lang="en">Abellán Alemán J., Sabaris R.C., Pardo D.E., García Donaire J.A. et al. En representación de la Sociedad Española de Hipertensión y las Sociedades Autonómicas de Hipertensión y Riesgo Vascular de España. Documento de consenso sobre tabaquismo y riesgo vascular. Hipertens. Riesgo Vasc. 2024; 41(suppl. 1);S1–S85. DOI: https://doi.org/10.1016/S1889-1837(24)00075-8 (in Spanish).</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Crean A.M., Adler A., Arbour L., Chan J. et al. Canadian Cardiovascular Society clinical practice update on contemporary management of the patient with hypertrophic cardiomyopathy. Can. J. Cardiol. 2024. Vol. 40, N 9. P. 1503–1523. DOI: https://doi.org/10.1016/j.cjca.2024.06.007</mixed-citation><mixed-citation xml:lang="en">Crean A.M., Adler A., Arbour L., Chan J. et al. Canadian Cardiovascular Society clinical practice update on contemporary management of the patient with hypertrophic cardiomyopathy. Can. J. Cardiol. 2024. Vol. 40, N 9. P. 1503–1523. DOI: https://doi.org/10.1016/j.cjca.2024.06.007</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Virani S.S., Newby L.K., Arnold S.V., Bittner V. et al. 2023 AHA/ ACC/ACCP/ ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023; 148(9); e9–e119. DOI: https://doi.org/10.1161/CIR.0000000000001168 Erratum in: Circulation. 2023;148(13); e148. DOI: https://doi.org/10.1161/CIR.0000000000001183 Erratum in:Circulation.2023;148(23);e186. DOI: https://doi.org/10.1161/CIR.0000000000001195</mixed-citation><mixed-citation xml:lang="en">Virani S.S., Newby L.K., Arnold S.V., Bittner V. et al. 2023 AHA/ ACC/ACCP/ ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023; 148(9); e9–e119. DOI: https://doi.org/10.1161/CIR.0000000000001168 Erratum in: Circulation. 2023;148(13); e148. DOI: https://doi.org/10.1161/CIR.0000000000001183 Erratum in:Circulation.2023;148(23);e186. DOI: https://doi.org/10.1161/CIR.0000000000001195</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Консенсус по борьбе с табакокурением у пациентов с метаболическим синдромом. Эндокринология: новости, мнения, обучение. 2025;14(3);74-91. DOI: https://doi.org/10.33029/2304-9529-2025-14-3-74-91.</mixed-citation><mixed-citation xml:lang="en">Consensus on tobacco control in patients with metabolic syndrome. Endocrinology: news, opinions, training. 2025;14(3);74-91 (In Russian). DOI: https://doi.org/10.33029/2304-9529-2025-14-3-74-91</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Тищенко О.В., Кривенко Л.С., Гаргина В.В. Влияние курения, нагревания табачных изделий и электронных сигарет на микробиоту зубного налета. Pol. Merkur. Lekarski. 2022;50(295):16–20. PMID: 35278292</mixed-citation><mixed-citation xml:lang="en">Tishchenko O.V., Krivenko L.S., Gargina V.V. The effect of smoking., heating tobacco products and electronic cigarettes on the plaque microbiota. Pol. Merkur. Lekarski. 2022;50(295):16–20. (In Russian). PMID: 35278292</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Benowitz N.L., Barua R.S., Rigotti N.A. et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol. 2018; 72(25);3332– 3365. DOI: https://doi.org/10.1016/j.jacc.2018.10.027</mixed-citation><mixed-citation xml:lang="en">Benowitz N.L., Barua R.S., Rigotti N.A. et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol. 2018; 72(25);3332– 3365. DOI: https://doi.org/10.1016/j.jacc.2018.10.027</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Lindson N., Butler A.R., McRobbie H., Bullen C., Hajek P., Wu A.D. et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst. Rev. 2025;1. CD010216. DOI: https://doi.org/10.1002/14651858.CD010216.pub9</mixed-citation><mixed-citation xml:lang="en">Lindson N., Butler A.R., McRobbie H., Bullen C., Hajek P., Wu A.D. et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst. Rev. 2025;1. CD010216. DOI: https://doi.org/10.1002/14651858.CD010216.pub9</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Hartmann-Boyce J., Lindson N., Butler A.R., McRobbie H., Bullen C., Hajek P. et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst. Rev. 2024;1. CD010216. DOI: https://doi.org/10.1002/14651858.CD010216.pub8</mixed-citation><mixed-citation xml:lang="en">Hartmann-Boyce J., Lindson N., Butler A.R., McRobbie H., Bullen C., Hajek P. et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst. Rev. 2024;1. CD010216. DOI: https://doi.org/10.1002/14651858.CD010216.pub8</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Choi S., Lee K., Park S.M. Combined associations of changes in noncombustible nicotine or tobacco product and combustible cigarette use habits with subsequent short-term cardiovascular disease risk among South Korean men: a nationwide cohort study. Circulation. 2021; 144(19);1528–1538. DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.054967 Erratum in: Circulation. 2021;144(19);e306. PMID: 34601948</mixed-citation><mixed-citation xml:lang="en">Choi S., Lee K., Park S.M. Combined associations of changes in noncombustible nicotine or tobacco product and combustible cigarette use habits with subsequent short-term cardiovascular disease risk among South Korean men: a nationwide cohort study. Circulation. 2021; 144(19);1528–1538. DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.054967 Erratum in: Circulation. 2021;144(19);e306. PMID: 34601948</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Wong J.M., Esfahani A., Singh N., Villa C.R., Mirrahimi A., Jenkins D.J., Kendall C.W. Gut microbiota., diet., and heart disease. J. AOAC Int. 2012;95(1):24–30. DOI: 10.5740/jaoacint.sge_wong</mixed-citation><mixed-citation xml:lang="en">Wong J.M., Esfahani A., Singh N., Villa C.R., Mirrahimi A., Jenkins D.J., Kendall C.W. Gut microbiota., diet., and heart disease. J. AOAC Int. 2012;95(1):24–30. DOI: 10.5740/jaoacint.sge_wong</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Hara H., Haga S., Aoyama Y., Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J. Nutr. 1999;129(5):942–8. DOI: 10.1093/jn/129.5.942</mixed-citation><mixed-citation xml:lang="en">Hara H., Haga S., Aoyama Y., Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J. Nutr. 1999;129(5):942–8. DOI: 10.1093/jn/129.5.942</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Agnello M., Cen L., Tran NC., Shi W., McLean J.S., He X. Arginine improves pH homeostasis via metabolism and microbiome modulation. J. Dent Res. 2017;96(8):924–930. DOI: 10.1177/0022034517707512</mixed-citation><mixed-citation xml:lang="en">Agnello M., Cen L., Tran NC., Shi W., McLean J.S., He X. Arginine improves pH homeostasis via metabolism and microbiome modulation. J. Dent Res. 2017;96(8):924–930. DOI: 10.1177/0022034517707512</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Agnello M., Cen L., Tran N.C., Shi W., McLean JS., He X. Arginine improves pH homeostasis via metabolism and microbiome modulation. J. Dent Res. 2017;96(8):924–930. DOI: 10.1177/0022034517707512</mixed-citation><mixed-citation xml:lang="en">Agnello M., Cen L., Tran N.C., Shi W., McLean JS., He X. Arginine improves pH homeostasis via metabolism and microbiome modulation. J. Dent Res. 2017;96(8):924–930. DOI: 10.1177/0022034517707512</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen T., Brody H., Lin GH., Rangé H., Kuraji R., Ye C., Kamarajan P., Radaic A., Gao L., Kapila Y. Probiotics., including nisin-based probiotics., improve clinical and microbial outcomes relevant to oral and systemic diseases. Periodontol. 2020;82(1):173– 185. DOI: 10.1111/prd.12324</mixed-citation><mixed-citation xml:lang="en">Nguyen T., Brody H., Lin GH., Rangé H., Kuraji R., Ye C., Kamarajan P., Radaic A., Gao L., Kapila Y. Probiotics., including nisin-based probiotics., improve clinical and microbial outcomes relevant to oral and systemic diseases. Periodontol. 2020;82(1):173– 185. DOI: 10.1111/prd.12324</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Vivekananda M.R., Vandana K.L., Bhat K.G. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J. Oral Microbiol. 2010;2. DOI: 10.3402/jom.v2i0.5344</mixed-citation><mixed-citation xml:lang="en">Vivekananda M.R., Vandana K.L., Bhat K.G. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J. Oral Microbiol. 2010;2. DOI: 10.3402/jom.v2i0.5344</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Zhen W., Wang Z., Wang Q., Sun W., Wang R., Zhang W. et al. Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective. Imeta. 2024;3(3):e197. DOI: 10.1002/imt2.197</mixed-citation><mixed-citation xml:lang="en">Zhen W., Wang Z., Wang Q., Sun W., Wang R., Zhang W. et al. Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective. Imeta. 2024;3(3):e197. DOI: 10.1002/imt2.197</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X.L., Chen W.J., Jin R., Xu X., Wei J., Huang H. et al. Engineered probiotics Clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models. Microb. Biotechnol. 2023;16(4):799–812. DOI: 10.1111/1751-7915.14196</mixed-citation><mixed-citation xml:lang="en">Wang X.L., Chen W.J., Jin R., Xu X., Wei J., Huang H. et al. Engineered probiotics Clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models. Microb. Biotechnol. 2023;16(4):799–812. DOI: 10.1111/1751-7915.14196</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Lee M.F., Chiang C.H., Lin S.J., Song P.P., Liu H.C., Wu T.J., Lin W.W. Recombinant lactococcus lactis expressing ling zhi 8 protein ameliorates nonalcoholic fatty liver and early atherogenesis in cholesterol-fed rabbits. Biomed. Res. Int. 2020;2020:3495682. DOI: 10.1155/2020/3495682</mixed-citation><mixed-citation xml:lang="en">Lee M.F., Chiang C.H., Lin S.J., Song P.P., Liu H.C., Wu T.J., Lin W.W. Recombinant lactococcus lactis expressing ling zhi 8 protein ameliorates nonalcoholic fatty liver and early atherogenesis in cholesterol-fed rabbits. Biomed. Res. Int. 2020;2020:3495682. DOI: 10.1155/2020/3495682</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
